Xiaoyan Wang
Partner IC Member
Pharmaceuticals
Adagene
China
Biography
Dr. Xiaoyan Wang received her PhD in Biology from Chinese Academy of Sciences, and MBA from Shanghai Advanced Institution of Finance (SAIF) of Shanghai Jiao Tong University. She was a product specialist of genome analysis at Beckman Coulter, the Vice General Manager of Bioscience, the director of core facility in Shanghai Institute of Biochemistry and Cell Biology, the investment manager of China-Singapore Suzhou Industrial Park Venture Capital Co., Ltd., and the investment director of Oriza Seed Fund Management Co., Ltd. During Dr. Wang’s tenure at China-Singapore Suzhou Industrial Park Venture Capital and Oriza Seed Fund Management Co., Ltd, she led the investments in early or developing stage companies in medical devices, pharmaceuticals and medical services. She was in charge of 9 investments, including Innovent Biologics, CF PharmaTech, Bowing Medical, Ryan Nano, Sealand Technology, Tennor Therapeutics, etc. most of these companies have completed the follow-up financing. Dr. Wang has more than 10 years experience in medical industry, and years of experience in health industry equity investment. Now she is MD and partner of GP Healthcare Capital Co., Ltd.
Research Interest
Business, Management, Toxicology, Pharmacology
